Download presentation
Presentation is loading. Please wait.
Published bySteven Garrett Modified over 5 years ago
1
CALGB (Alliance): A Randomized Phase II Study to Assess the Efficacy of Pemetrexed or Sunitinib or Pemetrexed Plus Sunitinib in the Second-Line Treatment of Advanced Non–Small-Cell Lung Cancer Rebecca S. Heist, MD, Xiaofei Wang, PhD, Lydia Hodgson, MA, Gregory A. Otterson, MD, Thomas E. Stinchcombe, MD, Leena Gandhi, MD, Miguel A. Villalona-Calero, MD, Peter Watson, MD, Everett E. Vokes, MD, Mark A. Socinski, MD Journal of Thoracic Oncology Volume 9, Issue 2, Pages (February 2014) DOI: /JTO Copyright © 2014 International Association for the Study of Lung Cancer Terms and Conditions
2
FIGURE 1 CONSORT diagram. AST, aspartate transaminase, BP, blood pressure. Journal of Thoracic Oncology 2014 9, DOI: ( /JTO ) Copyright © 2014 International Association for the Study of Lung Cancer Terms and Conditions
3
FIGURE 2 A, Progression-free survival. B, Overall survival.
Journal of Thoracic Oncology 2014 9, DOI: ( /JTO ) Copyright © 2014 International Association for the Study of Lung Cancer Terms and Conditions
Similar presentations
© 2024 SlidePlayer.com Inc.
All rights reserved.